Botulinum toxin clinical uses

Botulinum toxin clinical uses are condition- and treatment-goal entry points. They help readers move from a real-world question, such as migraine, cervical dystonia, sweating, frown lines, or masseter prominence, toward the products, toxin types, anatomy, labels, and safety context that make the question interpretable.

Approval context

An indication page is not an approval table. Approved uses differ by product and region, and common clinical discussion does not make a use approved for every product. The U.S. FDA indication matrix summarizes current U.S. labeled indications, while the U.S. FDA approval timeline collects major FDA anchors for current U.S.-visible brands.

Clinical Use Directory

Use context	Main category	Best first reading
Chronic migraine	Therapeutic neurology	Patterned, repeat-session use strongly associated with Botox label context.
Cervical dystonia	Therapeutic movement disorder	Multi-muscle neck patterns connecting type A products and the type B Myobloc / Neurobloc pathway.
Blepharospasm	Therapeutic focal movement disorder	Periocular functional treatment near, but distinct from, aesthetic upper-face anatomy.
Hemifacial spasm	Therapeutic focal facial movement disorder	Facial movement control that should not be collapsed into cosmetic facial softening.
Hyperhidrosis	Therapeutic autonomic / glandular use	Sweat-gland signaling rather than skeletal-muscle weakening alone.
Limb spasticity	Therapeutic rehabilitation / neurology	Functional goals such as comfort, hygiene, bracing, gait, reach, or task performance.
Glabellar lines	Aesthetic facial use	Dynamic frown-line softening with product-specific aesthetic labels and unit caution.
Crow’s feet	Aesthetic facial use	Lateral canthal line softening near the eye and smile pattern.
Masseter hypertrophy	Aesthetic / functional lower-face context	Jawline prominence, chewing comfort, facial proportions, and regional practice norms.

How Indication Pages Should Be Read

Indication pages are useful because product pages alone do not answer every reader question. A brand page starts with product identity. An indication page starts with the clinical or aesthetic problem, then asks which product labels, toxin types, target anatomy, and practical variables matter.

The order matters. A condition can be associated with several products in public discussion, but that does not mean every product has the same approval, dose language, formulation, unit system, warning language, or regional availability.

Relationship Map

Question	Best next page
Which products are visible in the current U.S.-oriented brand graph?	Botulinum toxin brands
Which represented products have current U.S. labeled indications?	U.S. FDA indication matrix
Why are type A and type B not the same comparison group?	Type A vs type B
Why can units not be converted across brands?	Unit interpretation
Why does anatomy change safety and spread interpretation?	Injection anatomy overview
Which companies sit behind major products?	Botulinum toxin manufacturers

Coverage Boundaries

These pages avoid treatment instructions, dosing tables, and universal brand recommendations. They summarize the relationship between a use context and the current knowledge graph. Product-specific labels and regional regulatory records remain the authority for approved indications, warnings, preparation, and dosing language.

References

• DailyMed: BOTOX prescribing information
• Botulinum Toxin - StatPearls, NCBI Bookshelf